Pharmacokinetics of Midazolam, With and Without Concomitant Administration of Crobenetine in Healthy Male Subjects
NCT02269202 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2014-10-21
Summary
To assess the pharmacokinetics of midazolam with/without concomitant administration of crobenetine
Conditions
- Healthy
Interventions
- DRUG
-
Midazolam, tablet
- DRUG
-
Crobenetine, i.v. infusion
- DRUG
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
Eligibility
- Min Age
- 21 Years
- Max Age
- 50 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2002-02-28
- Primary Completion
- 2002-04-30
More Related Trials
-
Study to Evaluate the Effect of Multiple Doses of BIRT 2584 XX Tablets on the Pharmacokinetic Parameters of Midazolam in Healthy Male Volunteers
NCT02256748 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess the Effect of Multiple Doses of Tradipitant on CYP3A4 Using Midazolam as a Substrate in Healthy Subjects
NCT02621385 ·Status: COMPLETED ·Phase: PHASE1
-
Determine the Effect of Multiple Doses of AZD7325, CYP Study
NCT00790114 ·Status: COMPLETED ·Phase: PHASE1
-
A Midazolam Drug Interaction Study With PF-04171327
NCT00987038 ·Status: COMPLETED ·Phase: PHASE1
-
THE EFFECT OF MULTIPLE DOSES OF PF-06835919 ON THE PHARMACOKINETICS OF A SINGLE ORAL MIDAZOLAM DOSE IN HEALTHY PARTICIPANTS
NCT03916406 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Volunteers to Assess Effect of AZD6765 on Midazolam Blood Levels
NCT01069822 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy People to Test How Well Different Doses of BI 3000202 Are Tolerated and How They Affect the Way the Body Handles Midazolam
NCT06327256 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Multiple Doses of AZD6280 on the Pharmacokinetics of Midazolam (CYP3A4) and Caffeine (CYP1A2)
NCT00824057 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Examine the Effects of Entinostat on Midazolam in Healthy Adult Subjects
NCT03187015 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess Effect of BV100 on the Pharmacokinetics of Midazolam in Healthy Participants
NCT05537090 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I, Open Interaction Study Between GLPG0634 and Midazolam in Healthy Subjects
NCT01798979 ·Status: COMPLETED ·Phase: PHASE1
-
Multiple Doses of BI 207127 NA, BI 201335 NA Followed by the Combination of BI 207127 NA and BI 201335 NA in Healthy Male Volunteers
NCT02182401 ·Status: TERMINATED ·Phase: PHASE1
-
A Study to Investigate the Effect of ACT-132577 on the Pharmacokinetics of Midazolam and 1-hydroxy Midazolam in Healthy Male Subjects
NCT02841761 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Effect of Cefiderocol on the Pharmacokinetics (PK) of Midazolam in Healthy Participants
NCT05395104 ·Status: COMPLETED ·Phase: PHASE1
-
Study in Healthy Volunteers to Assess the Pharmacokinetics of Midazolam Administered Alone and in Combination With Vandetanib
NCT01544140 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess the Effect of AZD4831 on the Pharmacokinetics (Drug Behavior in the Body) of Midazolam
NCT05052710 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Effect of Multiple-Dose Administration of JNJ-42847922 on Midazolam and Warfarin in Healthy Participants
NCT02617810 ·Status: COMPLETED ·Phase: PHASE1
-
Analgesic Effects of Midazolam in Human Volunteers
NCT02629146 ·Status: COMPLETED ·Phase: PHASE4
-
Potential Pharmacokinetic Interaction Between Selexipag and Midazolam in Healthy Male Subjects
NCT02791815 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Trial of the Effect of Midazolam on the Cerebral Metabolism and Inflammatory Response in Patients With Moderate and Severe Traumatic Brain Injury
NCT02071407 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study of the Safety and Pharmacokinetics of JNJ-38518168 in Japanese and Caucasian Male Participants and the Effect of JNJ-38518168 on the Blood Levels of Midazolam
NCT01442532 ·Status: COMPLETED ·Phase: PHASE1
-
The Study is to Evaluate the Effect of Multiple Doses PF-06751979 on the Pharmacokinetics of Midazolam in Healthy Adults
NCT03126721 ·Status: COMPLETED ·Phase: PHASE1
-
Study To Evaluate The Effect Of Multiple Doses of CTP-543 On The Pharmacokinetics Of Single Doses of Midazolam In Healthy Subjects
NCT05467709 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics of Midazolam When Co-administered With HEC74647 and HEC110114
NCT05504876 ·Status: COMPLETED ·Phase: PHASE1
-
Midazolam Whole Body Physiologically Based Pharmacokinetic Model
NCT01973894 ·Status: COMPLETED